Grever M, Malspeis L
Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland.
Hematol Oncol Clin North Am. 1993 Feb;7(1):233-54.
Despite the major advances that have been made over the past few decades in the management of adult acute leukemia, a substantial number of the patients still die from the underlying disease. Therefore, it is essential that we vigorously pursue efforts to discover and develop novel therapeutic agents for the treatment of leukemia.
尽管在过去几十年里成人急性白血病的治疗取得了重大进展，但仍有相当数量的患者死于这种基础疾病。因此，我们必须大力努力去发现和开发治疗白血病的新型治疗药物。
